1.
Chinese Pediatric Emergency Medicine
;
(12): 618-622, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-752943
RESUMO
With the improvement of the treatment of neonatal respiratory distress syndrome,minimal-ly invasive pulmonary surfactant(PS)therapy is gradually considered to be a more ideal drug delivery method for PS because of its simpler operation and less airway damage,and it is a part of the lung protective strategy for premature infants. Therefore,this article reviewed the administration methods,advantages,research status and future problems of minimally invasive PS treatment technology.